Liposomal amphotericin B for complicated visceral leishmaniasis (kala-azar) in eastern Sudan: how effective is treatment for this neglected disease?

Salih, Niven A.; van Griensven, Johan; Chappuis, François; Antierens, Annick; Mumina, Ann; Hammam, Omar; Boulle, Philippa; Alirol, Emilie; Alnour, Mubarak; Elhag, Mousab S.; Manzi, Marcel; Kizito, Walter; Zachariah, Rony

doi:10.1111/tmi.12238

Scientific article

English

Liposomal amphotericin B for complicated visceral leishmaniasis (kala-azar) in eastern Sudan: how effective is treatment for this neglected disease?

ContributorsSalih, Niven A.; van Griensven, Johan; Chappuis, François; Antierens, Annick; Mumina, Ann; Hammam, Omar; Boulle, Philippa; Alirol, Emilie; Alnour, Mubarak; Elhag, Mousab S.; Manzi, Marcel; Kizito, Walter; Zachariah, Rony

Published inTM & IH. Tropical medicine and international health, vol. 19, no. 2, p. 146-152

Publication date2014

Abstract

objectives The aim of this study was to report the patient profile and treatment outcomes, including relapses, of patients with visceral leishmaniasis (VL) treated with liposomal amphotericin B (AmBisome) in Gedaref, Sudan.

Affiliation entities

Faculté de médecine / Section de médecine clinique / Département de santé et médecine communautaires

Citation (ISO format)

SALIH, Niven A. et al. Liposomal amphotericin B for complicated visceral leishmaniasis (kala-azar) in eastern Sudan: how effective is treatment for this neglected disease? In: TM & IH. Tropical medicine and international health, 2014, vol. 19, n° 2, p. 146–152. doi: 10.1111/tmi.12238

Article (Published version)

Identifiers

PID : unige:42444
DOI : 10.1111/tmi.12238
PMID : 24433217

Journal ISSN1360-2276

593views

0downloads

Creation14/10/2014 14:33:00

First validation14/10/2014 14:33:00

Update14/03/2023 22:20:18

Status update14/03/2023 22:20:17

Last indexation30/10/2024 21:01:19

Archive ouverte UNIGE

Liposomal amphotericin B for complicated visceral leishmaniasis (kala-azar) in eastern Sudan: how effective is treatment for this neglected disease?

objectives The aim of this study was to report the patient profile and treatment outcomes, including relapses, of patients with visceral leishmaniasis (VL) treated with liposomal amphotericin B (AmBisome) in Gedaref, Sudan.

Technical informations